Results 111 to 120 of about 470,402 (254)

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

The effects of impulsivity and proactive inhibition on reactive inhibition and the go process: insights from the stop signal task of vocal and manual responses

open access: yesFrontiers in Human Neuroscience, 2015
This study measured proactive and reactive response inhibition and their relationships with self-reported impulsivity. We examined the domains of both vocal and manual responding using a stop signal task (SST) with two stop probabilities: high and low ...
Leidy Janeth Castro-Meneses   +4 more
doaj   +1 more source

Duration reproduction with sensory feedback delay: differential involvement of perception and action time [PDF]

open access: yes, 2012
Previous research has shown that voluntary action can attract subsequent, delayed feedback events toward the action, and adaptation to the sensorimotor delay can even reverse motor-sensory temporal order judgments.
Hermann Josef Mueller   +4 more
core   +2 more sources

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Stop what you are not doing! Emotional pictures interfere with the task not to respond [PDF]

open access: yes, 2010
Previous research has shown that emotional stimuli interfere with ongoing activities One explanation is that these stimuli draw attention away from the primary task and thereby hamper the correct execution of the task Another explanation is that ...
De Houwer, Jan, Tibboel, Helen
core   +2 more sources

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Individual differences in stop‐related activity are inflated by the adaptive algorithm in the stop signal task

open access: yesHuman Brain Mapping, 2018
AbstractResearch using the Stop Signal Task employing an adaptive algorithm to accommodate individual differences often report inferior performance on the task in individuals with ADHD, OCD, and substance use disorders compared to non‐clinical controls. Furthermore, individuals with deficits in inhibitory control tend to show reduced neural activity in
D'Alberto   +33 more
openaire   +6 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Inseparability of Go and Stop in Inhibitory Control: Go Stimulus Discriminability Affects Stopping Behavior

open access: yesFrontiers in Neuroscience, 2016
Inhibitory control, the ability to stop or modify preplanned actions under changing task conditions, is an important component of cognitive functions.
Ning eMa, Angela J Yu
doaj   +1 more source

Home - About - Disclaimer - Privacy